Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-26T01:01:37.032Z Has data issue: false hasContentIssue false
  • English
  • Français

A Précis of Recent Advances in the Neuropsychology of Mild Cognitive Impairment(s) in Parkinson's Disease and a Proposal of Preliminary Research Criteria

Published online by Cambridge University Press:  08 April 2011

Alexander I. Tröster
Alexander I. Tröster*
Affiliation:
Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, North Carolina
*
Correspondence and reprint requests to: Alexander I. Tröster, Department of Neurology (CB 7025), University of North Carolina at Chapel Hill, 3128 Physicians’ Office Building, 170 Manning Drive, Chapel Hill, NC 27599-7025. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Cognitive changes of Parkinson's disease (PD) manifest earlier and are more heterogeneous than previously appreciated. Approximately one-third of patients have at least mild cognitive changes at PD diagnosis, and subtle changes might be appreciable among those at risk for PD. Executive dysfunction is the most common cognitive change, but other phenotypes exist. Pathobiologic and potential prognostic differences among cognitive phenotypes remain poorly understood. Progress in the neuropsychology, epidemiology and pathobiology of mild cognitive impairment (MCI) in PD is hampered by lack of diagnostic criteria. This study proposes preliminary research criteria for two categories of PD non-dementia cognitive impairment. (JINS, 2011, 17, 393–406)

Keywords

Lewy body diseaseDementiaMemory disordersExecutive functionAttentionBiological markers
Type
Short Reviews
Information
Journal of the International Neuropsychological Society , Volume 17 , Issue 3 , May 2011 , pp. 393 - 406
Copyright
Copyright © The International Neuropsychological Society 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Aarsland, D., Bronnick, K., Larsen, J.P., Tysnes, O.B., Alves, G. (2009). Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest study. Neurology, 72, 1121–1126. doi:01.wnl.0000338632.00552.cb [pii] 10.1212/01.wnl.0000338632.00552.cbCrossRefGoogle ScholarPubMed
Aarsland, D., Bronnick, K., Williams-Gray, C., Weintraub, D., Marder, K., Kulisevsky, J., Emre, M. (2010). Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis. Neurology, 75, 1062–1069. doi:75/12/1062 [pii] 10.1212/WNL.0b013e3181f39d0eCrossRefGoogle ScholarPubMed
Aarsland, D., Londos, E., Ballard, C. (2009). Parkinson's disease dementia and dementia with Lewy bodies: Different aspects of one entity. International Psychogeriatrics, 21, 216–219. doi:S1041610208008612 [pii] 10.1017/S1041610208008612CrossRefGoogle ScholarPubMed
Adler, C.H., Caviness, J.N., Sabbagh, M.N., Shill, H.A., Connor, D.J., Sue, L., Beach, T.G. (2010). Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairment. Acta Neuropathologica, 120, 827–828. doi:10.1007/s00401-010-0744-4CrossRefGoogle ScholarPubMed
Alcalay, R.N., Mejia-Santana, H., Tang, M.X., Rakitin, B., Rosado, L., Ross, B., Caccappolo, E. (2010). Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. Journal of Clinical and Experimental Neuropsychology, 32, 775–779. doi:919484122 [pii] 10.1080/13803390903521018CrossRefGoogle ScholarPubMed
Alves, G., Bronnick, K., Aarsland, D., Blennow, K., Zetterberg, H., Ballard, C., Mulugeta, E. (2010). CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: The Norwegian ParkWest study. Journal of Neurology, Neurosurgery, and Psychiatry, 81, 1080–1086. doi:jnnp.2009.199950 [pii] 10.1136/jnnp.2009.199950CrossRefGoogle ScholarPubMed
Ballard, C., Ziabreva, I., Perry, R., Larsen, J.P., O'Brien, J., McKeith, I., Aarsland, D. (2006). Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology, 67, 1931–1934.CrossRefGoogle ScholarPubMed
Bangen, K.J., Jak, A.J., Schiehser, D.M., Delano-Wood, L., Tuminello, E., Han, S.D., Bondi, M.W. (2010). Complex activities of daily living vary by mild cognitive impairment subtype. Journal of the International Neuropsychological Society, 16, 630–639. doi:S1355617710000330 [pii] 10.1017/S1355617710000330CrossRefGoogle ScholarPubMed
Benedict, R.H. (1997). Brief Visuospatial Memory Test – revised: Professional manual. Lutz, FL: Psychological Assessment Resources.Google Scholar
Benton, A.L., Hamsher, K., Sivan, A.B. (1994). Multilingual aphasia examination (3rd ed.). Iowa City: AJA Associates.Google Scholar
Benton, A.L., Varney, N.R., Hamsher, K.D. (1978). Visuospatial judgment. A clinical test. Archives of Neurology, 35, 364–367.CrossRefGoogle ScholarPubMed
Bohnen, N.I., Kaufer, D.I., Hendrickson, R., Constantine, G.M., Mathis, C.A., Moore, R.Y. (2007). Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 78, 641–643.CrossRefGoogle ScholarPubMed
Bohnen, N.I., Kaufer, D.I., Hendrickson, R., Ivanco, L.S., Lopresti, B.J., Constantine, G.M., Dekosky, S.T. (2006). Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. Journal of Neurology, 253, 242–247.CrossRefGoogle ScholarPubMed
Braak, H., Rub, U., Jansen Steur, E.N., Del Tredici, K., de Vos, R.A. (2005). Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology, 64, 1404–1410.CrossRefGoogle ScholarPubMed
Braak, H., Tredici, K.D., Rüb, U., de Vos, R.A., Jansen Steur, E.N., Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging, 24, 197–211.CrossRefGoogle ScholarPubMed
Brandt, J., Benedict, R.H. (2001). The Hopkins Verbal Learning Test – Revised. Lutz, FL: Psychological Assessment Resources.Google Scholar
Brown, R.G., MacCarthy, B., Jahanshahi, M., Marsden, C.D. (1989). Accuracy of self-reported disability in patients with parkinsonism. Archives of Neurology, 46, 955–959.CrossRefGoogle ScholarPubMed
Buschke, H. (1973). Selective reminding for analysis of memory and learning. Journal of Verbal Learning and Verbal Behavior, 12, 543–550.CrossRefGoogle Scholar
Caviness, J.N., Driver-Dunckley, E., Connor, D.J., Sabbagh, M.N., Hentz, J.G., Noble, B., Adler, C.H. (2007). Defining mild cognitive impairment in Parkinson's disease. Movement Disorders, 22, 1272–1277.CrossRefGoogle ScholarPubMed
Choi, S.H., Jung, T.M., Lee, J.E., Lee, S.K., Sohn, Y.H., Lee, P.H. (2011). Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status. Neurobiology of Aging. doi:S0197-4580(10)00498-7 [pii] 10.1016/j.neurobiolaging.2010.11.015Google ScholarPubMed
Cools, R., Stefanova, E., Barker, R.A., Robbins, T.W., Owen, A.M. (2002). Dopaminergic modulation of high-level cognition in Parkinson's disease: The role of the prefrontal cortex revealed by PET. Brain, 125, 584–594.CrossRefGoogle ScholarPubMed
Cooper, J.A., Sagar, H.J., Jordan, N., Harvey, N.S., Sullivan, E.V. (1991). Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain, 114, 2095–2122.CrossRefGoogle ScholarPubMed
Delis, D.C., Kaplan, E., Kramer, J.H. (2001). Delis-Kaplan Executive Function System (D-KEFS). San Antonio: The Psychological Corporation.Google Scholar
Delis, D.C., Kramer, J.H., Kaplan, E., Ober, B.A. (2000). California Verbal Learning Test – adult version (2nd ed.). San Antonio: The Psychological Corporation.Google Scholar
Dubois, B. (2007). Is PD-MCI a useful concept? Movement Disorders, 22, 1215–1216.CrossRefGoogle ScholarPubMed
Edison, P., Rowe, C.C., Rinne, J.O., Ng, S., Ahmed, I., Kemppainen, N., Brooks, D.J. (2008). Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. Journal of Neurology, Neurosurgery, and Psychiatry, 79, 1331–1338. doi:jnnp.2007.127878 [pii] 10.1136/jnnp.2007.127878CrossRefGoogle ScholarPubMed
Elgh, E., Domellof, M., Linder, J., Edstrom, M., Stenlund, H., Forsgren, L. (2009). Cognitive function in early Parkinson's disease: A population-based study. European Journal of Neurology, 16, 1278–1284. doi:ENE2707 [pii] 10.1111/j.1468-1331.2009.02707.xCrossRefGoogle ScholarPubMed
Emre, M., Aarsland, D., Brown, R., Burn, D.J., Duyckaerts, C., Mizuno, Y., Dubois, B. (2007). Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders, 22, 1689–1707.CrossRefGoogle ScholarPubMed
Fernandez, H.H., Crucian, G.P., Okun, M.S., Price, C.C., Bowers, D. (2005). Mild cognitive impairment in Parkinson's disease: The challenge and the promise. Neuropsychiatric Disease and Treatment, 1, 37–50.CrossRefGoogle ScholarPubMed
Filoteo, J.V., Salmon, D.P., Schiehser, D.M., Kane, A.E., Hamilton, J.M., Rilling, L.M., Galasko, D.R. (2009). Verbal learning and memory in patients with dementia with Lewy bodies or Parkinson's disease with dementia. Journal of Clinical and Experimental Neuropsychology, 31, 823–834. doi:908749749 [pii] 10.1080/13803390802572401CrossRefGoogle ScholarPubMed
Foltynie, T., Brayne, C.E., Robbins, T.W., Barker, R.A. (2004). The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain, 127, 550–560.CrossRefGoogle ScholarPubMed
Foltynie, T., Goldberg, T.E., Lewis, S.G., Blackwell, A.D., Kolachana, B.S., Weinberger, D.R., Barker, R.A. (2004). Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism. Movement Disorders, 19, 885–891.CrossRefGoogle ScholarPubMed
Foltynie, T., Lewis, S.G., Goldberg, T.E., Blackwell, A.D., Kolachana, B.S., Weinberger, D.R., Barker, R.A. (2005). The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease. Journal of Neurology, 252, 833–838.CrossRefGoogle Scholar
Foster, E.R., Campbell, M.C., Burack, M.A., Hartlein, J., Flores, H.P., Cairns, N.J., Perlmutter, J.S. (2010). Amyloid imaging of Lewy body-associated disorders. Movement Disorders, 25, 2516–2523. doi:10.1002/mds.23393CrossRefGoogle ScholarPubMed
Gagnon, J.F., Vendette, M., Postuma, R.B., Desjardins, C., Massicotte-Marquez, J., Panisset, M., Montplaisir, J. (2009). Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Annals of Neurology, 66, 39–47. doi:10.1002/ana.21680CrossRefGoogle ScholarPubMed
Golden, C.J., Freshwater, S.M. (2002). Stroop Color and Word Test: A manual for clinical and experimental uses. Wood Dale, IL: Stoelting.Google Scholar
Gomperts, S.N., Rentz, D.M., Moran, E., Becker, J.A., Locascio, J.J., Klunk, W.E., Johnson, K.A. (2008). Imaging amyloid deposition in Lewy body diseases. Neurology, 71, 903–910. doi:71/12/903 [pii] 10.1212/01.wnl.0000326146.60732.d6CrossRefGoogle ScholarPubMed
Goodglass, H., Kaplan, E. (1983). The assessment of aphasia and related disorders (2nd ed.). Boston: Lea & Febiger.Google Scholar
Goris, A., Williams-Gray, C.H., Clark, G.R., Foltynie, T., Lewis, S.J., Brown, J., Sawcer, S.J. (2007). Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Annals of Neurology, 62, 145–153. doi:10.1002/ana.21192CrossRefGoogle ScholarPubMed
Halliday, G.M., McCann, H. (2010). The progression of pathology in Parkinson's disease. Annals of the New York Academy of Sciences, 1184, 188–195. doi:NYAS5118 [pii] 10.1111/j.1749-6632.2009.05118.xCrossRefGoogle ScholarPubMed
Hawkins, K., Jennings, D., Marek, K., Siderowf, A., Stern, M., PARS Study Investigators (2010). Cognitive deficits associated with dopamine transporter loss in the pre-motor subjects in the PARS cohort. Movement Disorders, 25(Suppl. 3), S690–S691.Google Scholar
Healy, D.G., Falchi, M., O'Sullivan, S.S., Bonifati, V., Durr, A., Bressman, S., Wood, N.W. (2008). Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: A case-control study. Lancet Neurology, 7, 583–590. doi:S1474-4422(08)70117-0 [pii] 10.1016/S1474-4422(08)70117-0CrossRefGoogle ScholarPubMed
Heaton, R.K., Chelune, G.J., Talley, J.L., Kay, G.G., Curtiss, G. (1993). Wisconsin Card Sorting Test Manual. Odessa: Psychological Assessment Resources.Google Scholar
Hoogland, J., de Bie, R.M., Williams-Gray, C.H., Muslimovic, D., Schmand, B., Post, B. (2010). Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease. Movement Disorders, 25, 2550–2554. doi:10.1002/mds.23319CrossRefGoogle ScholarPubMed
Hooper, H.E. (1983). Hooper Visual Organization Test. Los Angeles, CA: Western Psychological Services.Google Scholar
Hoops, S., Nazem, S., Siderowf, A.D., Duda, J.E., Xie, S.X., Stern, M.B., Weintraub, D. (2009). Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology, 73, 1738–1745. doi:73/21/1738 [pii] 10.1212/WNL.0b013e3181c34b47CrossRefGoogle ScholarPubMed
Hosokai, Y., Nishio, Y., Hirayama, K., Takeda, A., Ishioka, T., Sawada, Y., Mori, E. (2009). Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment. Movement Disorders, 24, 854–862. doi:10.1002/mds.22444CrossRefGoogle ScholarPubMed
Huang, C., Mattis, P., Perrine, K., Brown, N., Dhawan, V., Eidelberg, D. (2008). Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology, 70, 1470–1477. doi:01.wnl.0000304050.05332.9c [pii] 10.1212/01.wnl.0000304050.05332.9cCrossRefGoogle ScholarPubMed
Huang, X., Chen, P., Kaufer, D.I., Troster, A.I., Poole, C. (2006). Apolipoprotein E and dementia in Parkinson disease: A meta-analysis. Archives of Neurology, 63, 189–193.CrossRefGoogle ScholarPubMed
Jacobs, D.M., Marder, K., Cote, L.J., Sano, M., Stern, Y., Mayeux, R. (1995). Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology, 45, 1691–1696.CrossRefGoogle ScholarPubMed
Jak, A.J., Bondi, M.W., Delano-Wood, L., Wierenga, C., Corey-Bloom, J., Salmon, D.P., Delis, D.C. (2009). Quantification of five neuropsychological approaches to defining mild cognitive impairment. American Journal of Geriatric Psychiatry, 17, 368–375. doi:10.1097/JGP.0b013e31819431d5 00019442-200905000-00004 [pii]CrossRefGoogle ScholarPubMed
Janvin, C.C., Aarsland, D., Larsen, J.P. (2005). Cognitive predictors of dementia in Parkinson's disease: A community-based, 4-year longitudinal study. Journal of Geriatric Psychiatry and Neurology, 18, 149–154.CrossRefGoogle ScholarPubMed
Janvin, C.C., Larsen, J.P., Aarsland, D., Hugdahl, K. (2006). Subtypes of mild cognitive impairment in Parkinson's disease: Progression to dementia. Movement Disorders, 21, 1343–1349.CrossRefGoogle ScholarPubMed
Jeste, D., Blacker, D., Blazer, D., Ganguli, M., Grant, I., Paulsen, J., Sachdev, S. (2010). Neurocognitive disorders: A proposal from the DSM-5 Neurocognitive Disorders Work Group. Retrieved from http://www.dsm5.org/Proposed%20Revision%20Attachments/APA%20Neurocognitive%20Disorders%20Proposal%20for%20DSM-5.pdfGoogle Scholar
Jokinen, P., Scheinin, N., Aalto, S., Nagren, K., Savisto, N., Parkkola, R., Rinne, J.O. (2010). [(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia. Parkinsonism and Related Disorders, 16, 666–670. doi:S1353-8020(10)00219-1 [pii] 10.1016/j.parkreldis.2010.08.021CrossRefGoogle Scholar
Kalbe, E., Calabrese, P., Kohn, N., Hilker, R., Riedel, O., Wittchen, H.U., Kessler, J. (2008). Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism and Related Disorders, 14, 93–101. doi:S1353-8020(07)00103-4 [pii] 10.1016/j.parkreldis.2007.06.008CrossRefGoogle ScholarPubMed
Kaplan, E., Goodglass, H., Weintraub, S. (1983). Boston Naming Test. Philadelphia: Lea & Febiger.Google Scholar
Klein, J.C., Eggers, C., Kalbe, E., Weisenbach, S., Hohmann, C., Vollmar, S., Hilker, R. (2010). Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology, 74, 885–892. doi:WNL.0b013e3181d55f61 [pii] 10.1212/WNL.0b013e3181d55f61CrossRefGoogle ScholarPubMed
Kulisevsky, J., Pagonabarraga, J., Pascual-Sedano, B., Garcia-Sanchez, C., Gironell, A. (2008). Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia. Movement Disorders, 23, 1889–1896. doi:10.1002/mds.22246CrossRefGoogle ScholarPubMed
Leverenz, J.B., Stennis Watson, G., Shofer, J., Zabetian, C.P., Zhang, J., Montine, T.J. (2010). Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease. Parkinsonism and Related Disorders. doi:S1353-8020(10)00250-6 [pii] 10.1016/j.parkreldis.2010.10.003Google ScholarPubMed
Levin, B.E., Katzen, H.L. (1995). Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease. In W.J. Weiner & A.E. Lang (Eds.),, Advances in neurology: Behavioral neurology of movement disorders (65, pp. 85–95). New York: Raven Press.Google Scholar
Lohmann, E., Thobois, S., Lesage, S., Broussolle, E., du Montcel, S.T., Ribeiro, M.J., Brice, A. … (2009). A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology, 72, 110–116. doi:01.wnl.0000327098.86861.d4 [pii] 10.1212/01.wnl.0000327098.86861.d4CrossRefGoogle ScholarPubMed
Maetzler, W., Liepelt, I., Reimold, M., Reischl, G., Solbach, C., Becker, C., Berg, D. (2009). Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics. Neurobiology of Disease, 34, 107–112. doi:S0969-9961(08)00319-7 [pii] 10.1016/j.nbd.2008.12.008CrossRefGoogle ScholarPubMed
Mahieux, F., Fenelon, G., Flahault, A., Manifacier, M.J., Michelet, D., Boller, F. (1998). Neuropsychological prediction of dementia in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 64, 178–183.CrossRefGoogle ScholarPubMed
Mamikonyan, E., Moberg, P.J., Siderowf, A., Duda, J.E., Have, T.T., Hurtig, H.I., Weintraub, D. (2009). Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism and Related Disorders, 15, 226–231. doi:S1353-8020(08)00163-6 [pii] 10.1016/j.parkreldis.2008.05.006CrossRefGoogle ScholarPubMed
Marder, K. (2010). Cognitive impairment and dementia in Parkinson's disease. Movement Disorders, 25(Suppl. 1), S110–S116. doi:10.1002/mds.22787CrossRefGoogle ScholarPubMed
Marinus, J., Visser, M., Verwey, N.A., Verhey, F.R., Middelkoop, H.A., Stiggelbout, A.M., van Hilten, J.J. (2003). Assessment of cognition in Parkinson's disease. Neurology, 61, 1222–1228.CrossRefGoogle ScholarPubMed
Marsh, L., Biglan, K., Gerstenhaber, M., Williams, J.R. (2009). Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study. Movement Disorders, 24, 277–282. doi:10.1002/mds.22307CrossRefGoogle ScholarPubMed
Mattila, P.M., Roytta, M., Lonnberg, P., Marjamaki, P., Helenius, H., Rinne, J.O. (2001). Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment. Acta Neuropathologica, 102, 160–166.CrossRefGoogle ScholarPubMed
Mattis, S. (2001). Dementia Rating Scale-2. Lutz, FL: Psychological Assessment Resources.Google Scholar
McKeith, I.G. (2009). Commentary: DLB and PDD: the same or different? Is there a debate? International Psychogeriatrics, 21, 220–224. doi:S1041610208008624 [pii] 10.1017/S1041610208008624CrossRefGoogle ScholarPubMed
Metzler-Baddeley, C. (2007). A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia. Cortex, 43, 583–600.CrossRefGoogle ScholarPubMed
Molano, J., Boeve, B., Ferman, T., Smith, G., Parisi, J., Dickson, D., Petersen, R. (2010). Mild cognitive impairment associated with limbic and neocortical Lewy body disease: A clinicopathological study. Brain, 133, 540–556. doi:awp280 [pii] 10.1093/brain/awp280CrossRefGoogle ScholarPubMed
Montine, T.J., Shi, M., Quinn, J.F., Peskind, E.R., Craft, S., Ginghina, C., Zhang, J. (2010). CSF Abeta(42) and tau in Parkinson's disease with cognitive impairment. Movement Disorders. doi:10.1002/mds.23287CrossRefGoogle ScholarPubMed
Muslimovic, D., Post, B., Speelman, J.D., De Haan, R.J., Schmand, B. (2009). Cognitive decline in Parkinson's disease: A prospective longitudinal study. Journal of the International Neuropsychological Society, 15, 426–437. doi:S1355617709090614 [pii] 10.1017/S1355617709090614CrossRefGoogle ScholarPubMed
Muslimovic, D., Post, B., Speelman, J.D., Schmand, B. (2005). Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology, 65, 1239–1245.CrossRefGoogle ScholarPubMed
Muslimovic, D., Schmand, B., Speelman, J.D., De Haan, R.J. (2007). Course of cognitive decline in Parkinson's disease: A meta-analysis. Journal of the International Neuropsychological Society, 13, 920–932.CrossRefGoogle ScholarPubMed
Naismith, S.L., Pereira, M., Shine, J.M., Lewis, S.J. (2010). How well do caregivers detect mild cognitive change in Parkinson's disease? Movement Disorders. doi:10.1002/mds.23331Google ScholarPubMed
Nasreddine, Z.S., Phillips, N.A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695–699. doi:JGS53221 [pii] 10.1111/j.1532-5415.2005.53221.xCrossRefGoogle Scholar
Nelson, H.E., Willison, J. (1991). National Adult Reading Test (NART): Test manual (2nd ed.). Windsor, UK: NFER-Nelson.Google Scholar
Nobili, F., Abbruzzese, G., Morbelli, S., Marchese, R., Girtler, N., Dessi, B., Rodriguez, G. (2009). Amnestic mild cognitive impairment in Parkinson's disease: A brain perfusion SPECT study. Movement Disorders, 24, 414–421. doi:10.1002/mds.22381CrossRefGoogle ScholarPubMed
Nobili, F., Campus, C., Arnaldi, D., De Carli, F., Cabassi, G., Brugnolo, A., Rodriguez, G. (2010). Cognitive-nigrostriatal relationships in de novo, drug-naive Parkinson's disease patients: A [I-123]FP-CIT SPECT study. Movement Disorders, 25, 35–43. doi:10.1002/mds.22899CrossRefGoogle ScholarPubMed
Noe, E., Marder, K., Bell, K.L., Jacobs, D.M., Manly, J.J., Stern, Y. (2004). Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Movement Disorders, 19, 60–67.CrossRefGoogle ScholarPubMed
Owen, A.M., Iddon, J.L., Hodges, J.R., Summers, B.A., Robbins, T.W. (1997). Spatial and non-spatial working memory at different stages of Parkinson's disease. Neuropsychologia, 35, 519–532.CrossRefGoogle ScholarPubMed
Owen, A.M., Sahakian, B.J., Hodges, J.R., Summers, B.A., Polkey, C.E., Robbins, T.W. (1995). Dopamine-dependent fronto-striatal planning deficits in early Parkinson's disease. Neuropsychology, 9, 126–140.CrossRefGoogle Scholar
Pagonabarraga, J., Kulisevsky, J., Llebaria, G., Garcia-Sanchez, C., Pascual-Sedano, B., Gironell, A. (2008). Parkinson's disease-cognitive rating scale: A new cognitive scale specific for Parkinson's disease. Movement Disorders, 23, 998–1005. doi:10.1002/mds.22007CrossRefGoogle Scholar
Palmer, B.W., Boone, K.B., Lesser, I.M., Wohl, M.A. (1998). Base rates of “impaired” neuropsychological test performance among healthy older adults. Archives of Clinical Neuropsychology, 13, 503–511. doi:S0887617797000371 [pii]Google ScholarPubMed
Piatt, A.L., Fields, J.A., Paolo, A.M., Koller, W.C., Tröster, A.I. (1999). Lexical, semantic, and action verbal fluency in Parkinson's disease with and without dementia. Journal of Clinical and Experimental Neuropsychology, 21, 435–443.CrossRefGoogle ScholarPubMed
Piccirilli, M., D'Alessandro, P., Finali, G., Piccinin, G.L., Agostini, L. (1989). Frontal lobe dysfunction in Parkinson's disease: Prognostic value for dementia? European Neurology, 29, 71–76.CrossRefGoogle ScholarPubMed
Raven, J., Raven, J.C., Court, J.H. (2003). Manual for Raven's Progressive Matrices and Vocabulary Scales. San Antonio, TX: The Psychological Corporation.Google Scholar
Reid, W.G., Hely, M.A., Morris, J.G., Broe, G.A., Adena, M., Sullivan, D.J., Williamson, P.M. (1996). A longitudinal study of Parkinson's disease: Clinical and neuropsychological correlates of dementia. Journal of Clinical Neuroscience, 3, 327–333.CrossRefGoogle ScholarPubMed
Reitan, R.M., Wolfson, D. (1985). The Halstead-Reitan Neuropsychological Test Battery. Tucson: Neuropsychology Press.Google Scholar
Robbins, T.W., James, M., Owen, A.M., Sahakian, B.J., McInnes, L., Rabbitt, P. (1994). Cambridge Neuropsychological Test Automated Battery (CANTAB): A factor analytic study of a large sample of normal elderly volunteers. Dementia, 5, 266–281.Google ScholarPubMed
Sammer, G., Reuter, I., Hullmann, K., Kaps, M., Vaitl, D. (2006). Training of executive functions in Parkinson's disease. Journal of the Neurological Sciences, 248, 115–119. doi:S0022-510X(06)00224-3 [pii] 10.1016/j.jns.2006.05.028CrossRefGoogle ScholarPubMed
Schmidt, M. (1996). Rey Auditory and Verbal Learning Test: A handbook. Los Angeles, CA: Western Psychological Services.Google Scholar
Shimada, H., Hirano, S., Shinotoh, H., Aotsuka, A., Sato, K., Tanaka, N., Irie, T. (2009). Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology, 73, 273–278. doi:WNL.0b013e3181ab2b58 [pii] 10.1212/WNL.0b013e3181ab2b58CrossRefGoogle ScholarPubMed
Siderowf, A., Xie, S.X., Hurtig, H., Weintraub, D., Duda, J., Chen-Plotkin, A., Clark, C. (2010). CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease. Neurology, 75, 1055–1061. doi:WNL.0b013e3181f39a78 [pii] 10.1212/WNL.0b013e3181f39a78CrossRefGoogle ScholarPubMed
Sinforiani, E., Banchieri, L., Zucchella, C., Pacchetti, C., Sandrini, G. (2004). Cognitive rehabilitation in Parkinson's disease. Archives of Gerontology and Geriatrics. Supplement, 387–391.CrossRefGoogle ScholarPubMed
Sivan, A.B. (1991). Benton Viusal Retention Test (5th ed.). San Antonio, TX: The Psychological Corporation.Google Scholar
Smith, A. (1982). Symbol Digit Modalities Test. Los Angeles: Western Psychological Services.Google Scholar
Sollinger, A.B., Goldstein, F.C., Lah, J.J., Levey, A.I., Factor, S.A. (2010). Mild cognitive impairment in Parkinson's disease: Subtypes and motor characteristics. Parkinsonism and Related Disorders, 16, 177–180. doi:S1353-8020(09)00274-0 [pii] 10.1016/j.parkreldis.2009.11.002CrossRefGoogle ScholarPubMed
Song, I.U., Kim, J.S., Jeong, D.S., Song, H.J., Lee, K.S. (2008). Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia. Parkinsonism and Related Disorders, 14, 558–562. doi:S1353-8020(08)00027-8 [pii] 10.1016/j.parkreldis.2008.01.007CrossRefGoogle ScholarPubMed
Trenerry, M., Crosson, B., DeBoe, J., Leber, W. (1989). Stroop Neuropsychological Screening Test. Lutz, FL: Psychological Assessment Resources.Google Scholar
Tröster, A.I. (2008). Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: Differentiation, early detection, and implications for “mild cognitive impairment” and biomarkers. Neuropsychology Review, 18, 103–119. doi:10.1007/s11065-008-9055-0CrossRefGoogle ScholarPubMed
Tröster, A.I., Woods, S.P., Morgan, E.E. (2007). Assessing cognitive change in Parkinson's disease: Development of practice effect-corrected reliable change indices. Archives of Clinical Neuropsychology, 22, 711–718.CrossRefGoogle ScholarPubMed
Wechsler, D. (1997). Wechsler Memory Scale (3rd ed.). San Antonio: The Psychological Corporation.Google Scholar
Wechsler, D. (2008). Wechsler Adult Intelligence Scale (WAIS-IV) (4th ed.). San Antonio, TX: The Psyhcological Corporation.Google Scholar
Weintraub, D., Mavandadi, S., Mamikonyan, E., Siderowf, A.D., Duda, J.E., Hurtig, H.I., Stern, M.B. … (2010). Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology, 75, 448–455. doi:75/5/448 [pii] 10.1212/WNL.0b013e3181ebdd79CrossRefGoogle ScholarPubMed
Williams-Gray, C.H., Evans, J.R., Goris, A., Foltynie, T., Ban, M., Robbins, T.W., Barker, R.A. (2009). The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain, 132, 2958–2969. doi:awp245 [pii] 10.1093/brain/awp245CrossRefGoogle ScholarPubMed
Williams-Gray, C.H., Foltynie, T., Brayne, C.E., Robbins, T.W., Barker, R.A. (2007). Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain, 130, 1787–1798.CrossRefGoogle Scholar
Williams-Gray, C.H., Hampshire, A., Barker, R.A., Owen, A.M. (2008). Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype. Brain, 131, 397–408. doi:awm313 [pii] 10.1093/brain/awm313CrossRefGoogle ScholarPubMed
Woods, S.P., Tröster, A.I. (2003). Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease. Journal of the International Neuropsychological Society, 9, 17–24.CrossRefGoogle ScholarPubMed